• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对氧磷酶 1 的结构与功能及其与对氧磷酶 2 和 3 的比较。

The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3.

机构信息

Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.

出版信息

Molecules. 2020 Dec 17;25(24):5980. doi: 10.3390/molecules25245980.

DOI:10.3390/molecules25245980
PMID:33348669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7766523/
Abstract

Serum paraoxonase-1 (PON1) is the most studied member of the group of paraoxonases (PONs). This enzyme possesses three enzymatic activities: lactonase, arylesterase, and paraoxonase activity. PON1 and its isoforms play an important role in drug metabolism as well as in the prevention of cardiovascular and neurodegenerative diseases. Although all three members of the PON family have the same origin and very similar amino acid sequences, they have different functions and are found in different locations. PONs exhibit substrate promiscuity, and their true physiological substrates are still not known. However, possible substrates include homocysteine thiolactone, an analogue of natural quorum-sensing molecules, and the recently discovered derivatives of arachidonic acid-bioactive δ-lactones. Directed evolution, site-directed mutagenesis, and kinetic studies provide comprehensive insights into the active site and catalytic mechanism of PON1. However, there is still a whole world of mystery waiting to be discovered, which would elucidate the substrate promiscuity of a group of enzymes that are so similar in their evolution and sequence yet so distinct in their function.

摘要

血清对氧磷酶 1(PON1)是对氧磷酶(PONs)家族中研究最多的成员。这种酶具有三种酶活性:内酯酶、芳基酯酶和对氧磷酶活性。PON1 及其同工酶在药物代谢以及预防心血管和神经退行性疾病中发挥重要作用。尽管 PON 家族的所有三个成员都有相同的起源和非常相似的氨基酸序列,但它们具有不同的功能,并且存在于不同的位置。PON 表现出底物的混杂性,其真正的生理底物仍不清楚。然而,可能的底物包括同型半胱氨酸硫内酯,一种天然群体感应分子的类似物,以及最近发现的花生四烯酸生物活性 δ-内酯衍生物。定向进化、定点突变和动力学研究为 PON1 的活性位点和催化机制提供了全面的见解。然而,仍有一个充满神秘的世界有待发现,这将阐明一组在进化和序列上如此相似但在功能上却截然不同的酶的底物混杂性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/ce68fc144869/molecules-25-05980-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/a7b69b6554d5/molecules-25-05980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/d99b0981c3e4/molecules-25-05980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/fe1641f68600/molecules-25-05980-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/cd9b0c854014/molecules-25-05980-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/24d3633cd720/molecules-25-05980-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/ce68fc144869/molecules-25-05980-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/a7b69b6554d5/molecules-25-05980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/d99b0981c3e4/molecules-25-05980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/fe1641f68600/molecules-25-05980-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/cd9b0c854014/molecules-25-05980-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/24d3633cd720/molecules-25-05980-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8983/7766523/ce68fc144869/molecules-25-05980-g006.jpg

相似文献

1
The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3.对氧磷酶 1 的结构与功能及其与对氧磷酶 2 和 3 的比较。
Molecules. 2020 Dec 17;25(24):5980. doi: 10.3390/molecules25245980.
2
Paraoxonases-1, -2 and -3: What are their functions?对氧磷酶-1、-2和-3:它们的功能是什么?
Chem Biol Interact. 2016 Nov 25;259(Pt B):51-62. doi: 10.1016/j.cbi.2016.05.036. Epub 2016 May 26.
3
Identification of biologically active δ-lactone eicosanoids as paraoxonase substrates.鉴定具有生物活性的δ-内酯二十烷类化合物作为对氧磷酶的底物。
Biochem Biophys Res Commun. 2018 Oct 20;505(1):87-92. doi: 10.1016/j.bbrc.2018.09.083. Epub 2018 Sep 18.
4
Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.对人对氧磷酶 1 变体的特征分析表明,该酶的内酯酶/芳酯酶活性并非总是需要 115 和 134 位的组氨酸残基。
Protein Sci. 2013 Dec;22(12):1799-807. doi: 10.1002/pro.2380. Epub 2013 Oct 26.
5
The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.人对氧磷酶基因簇作为动脉粥样硬化治疗的靶点。
Antioxid Redox Signal. 2012 Mar 15;16(6):597-632. doi: 10.1089/ars.2010.3774. Epub 2011 Oct 18.
6
Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes.解毒及抗动脉粥样硬化酶血清对氧磷酶家族的结构与进化
Nat Struct Mol Biol. 2004 May;11(5):412-9. doi: 10.1038/nsmb767. Epub 2004 Apr 18.
7
Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.血清对氧磷酶PON1的结构-反应活性研究表明,其天然活性为内酯酶。
Biochemistry. 2005 Apr 26;44(16):6371-82. doi: 10.1021/bi047440d.
8
Signature of paraoxonases in the altered redox homeostasis in Alzheimer's disease.对氧磷酶在阿尔茨海默病氧化还原稳态改变中的作用特征
Chem Biol Interact. 2024 Jan 25;388:110839. doi: 10.1016/j.cbi.2023.110839. Epub 2023 Dec 22.
9
The paraoxonase 1, 2 and 3 in humans.人类的对氧磷酶 1、2 和 3。
Biochem Med (Zagreb). 2011;21(2):122-30. doi: 10.11613/bm.2011.020.
10
Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.迈向理解人类对氧磷酶1的催化机制:192位的位点特异性诱变
PLoS One. 2016 Feb 1;11(2):e0147999. doi: 10.1371/journal.pone.0147999. eCollection 2016.

引用本文的文献

1
Calcitriol Induces Paraoxonase 1 Expression in HepG2 Cells: Possible Involvement of VDR-Dependent and Alternative Pathways.骨化三醇诱导HepG2细胞中对氧磷酶1表达:维生素D受体依赖性及其他途径的可能参与
Int J Mol Sci. 2025 Aug 18;26(16):7948. doi: 10.3390/ijms26167948.
2
S-Nitrosylation: Mechanistic Links between Nitric Oxide Signaling and Atherosclerosis.S-亚硝基化:一氧化氮信号传导与动脉粥样硬化之间的机制联系
Curr Atheroscler Rep. 2025 Aug 7;27(1):78. doi: 10.1007/s11883-025-01321-y.
3
Intramolecular sensitization and structure of a Tb/2-hydroxyquinoline conjugate in the paraoxonase 1 active site.

本文引用的文献

1
Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma.血清对氧磷酶1作为评估肝细胞癌微血管侵犯的生物标志物。
Ann Transl Med. 2020 Mar;8(5):204. doi: 10.21037/atm.2020.01.44.
2
Molecular mechanism whereby paraoxonase-2 regulates coagulation activation through endothelial tissue factor in rat haemorrhagic shock model.载脂蛋白酶-2 通过血管内皮组织因子调控大鼠失血性休克模型凝血激活的分子机制。
Int Wound J. 2020 Jun;17(3):735-741. doi: 10.1111/iwj.13329. Epub 2020 Feb 23.
3
Enzyme Evolution: An Epistatic Ratchet versus a Smooth Reversible Transition.
对氧磷酶1活性位点中Tb/2-羟基喹啉共轭物的分子内敏化作用及结构
Dalton Trans. 2025 Jul 30. doi: 10.1039/d5dt01484k.
4
A Thermostable Bacterial Metallohydrolase that Degrades Organophosphate Plasticizers.一种可降解有机磷酸酯增塑剂的耐热细菌金属水解酶。
Chembiochem. 2025 Jun 3;26(11):e202500055. doi: 10.1002/cbic.202500055. Epub 2025 May 28.
5
Investigation of the Molecular Mechanisms of Paraoxonase-2 Mediated Radiotherapy and Chemotherapy Resistance in Oral Squamous Cell Carcinoma.对口腔鳞状细胞癌中对氧磷酶-2介导的放疗和化疗耐药分子机制的研究
Clin Transl Sci. 2025 Apr;18(4):e70201. doi: 10.1111/cts.70201.
6
Effects of experimental hepatic steatosis on apelin and various biochemical parameters in male white rabbits.实验性肝脂肪变性对雄性白兔apelin及各项生化指标的影响
Open Vet J. 2025 Jan;15(1):211-221. doi: 10.5455/OVJ.2025.v15.i1.20. Epub 2025 Jan 31.
7
PON-1 and PON-2 Polymorphisms and PON-1 Paraoxonase Activity in People Living with HIV-1.HIV-1感染者的对氧磷酶-1(PON-1)和对氧磷酶-2(PON-2)基因多态性及PON-1对氧磷酶活性
Antioxidants (Basel). 2025 Feb 12;14(2):209. doi: 10.3390/antiox14020209.
8
Human Paraoxonase 1: From Bloodstream Enzyme to Disease Fighter & Therapeutic Intervention.人对氧磷酶1:从血流中的酶到疾病抵御者及治疗干预手段
Curr Protein Pept Sci. 2025;26(4):282-295. doi: 10.2174/0113892037335325241011162207.
9
Molecular Structure of Paraoxonase-1 and Its Modifications in Relation to Enzyme Activity and Biological Functions-A Comprehensive Review.对氧磷酶-1的分子结构及其与酶活性和生物学功能相关的修饰——综述
Int J Mol Sci. 2024 Dec 6;25(23):13129. doi: 10.3390/ijms252313129.
10
Lactonase activity of α-carbonic anhydrases allows identification of novel inhibitors.α-碳酸酐酶的内酯酶活性有助于鉴定新型抑制剂。
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400705. doi: 10.1002/ardp.202400705. Epub 2024 Dec 9.
酶的进化:由上位性棘轮与平滑的可逆转变决定。
Mol Biol Evol. 2020 Apr 1;37(4):1133-1147. doi: 10.1093/molbev/msz298.
4
Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies.含亚胺和胺基的苯磺酰胺衍生物:对人对氧磷酶的抑制作用及分子对接研究。
Int J Biol Macromol. 2020 Mar 1;146:1111-1123. doi: 10.1016/j.ijbiomac.2019.09.237. Epub 2019 Nov 15.
5
Differential effects of selective serotonin reuptake inhibitors on paraoxonase-1 enzyme activity: An in vitro study.选择性 5-羟色胺再摄取抑制剂对对氧磷酶 1 酶活性的影响:一项体外研究。
Comp Biochem Physiol C Toxicol Pharmacol. 2019 Dec;226:108608. doi: 10.1016/j.cbpc.2019.108608. Epub 2019 Aug 15.
6
The behaviour of some antihypertension drugs on human serum paraoxonase-1: an important protector enzyme against atherosclerosis.一些抗高血压药物对人血清对氧磷酶-1 的作用:一种对抗动脉粥样硬化的重要保护酶。
J Pharm Pharmacol. 2019 Oct;71(10):1576-1583. doi: 10.1111/jphp.13144. Epub 2019 Jul 26.
7
Structure-activity relationship of atorvastatin derivatives for metabolic activation by hydrolases.阿托伐他汀衍生物经水解酶代谢活化的构效关系
Xenobiotica. 2020 Mar;50(3):261-269. doi: 10.1080/00498254.2019.1625083. Epub 2019 Jun 19.
8
The inhibition effects of some sulfonamides on human serum paraoxonase-1 (hPON1).某些磺胺类药物对人血清对氧磷酶-1(hPON1)的抑制作用。
Pharmacol Rep. 2019 Jun;71(3):545-549. doi: 10.1016/j.pharep.2019.02.012. Epub 2019 Feb 20.
9
Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3β RISK pathway.对氧磷酶 2 通过调节线粒体功能和氧化应激通过 PI3K/Akt/GSK-3β RISK 途径来保护急性心肌缺血再灌注损伤。
J Mol Cell Cardiol. 2019 Apr;129:154-164. doi: 10.1016/j.yjmcc.2019.02.008. Epub 2019 Feb 23.
10
PON2 Deficiency Leads to Increased Susceptibility to Diet-Induced Obesity.PON2缺乏会导致对饮食诱导的肥胖易感性增加。
Antioxidants (Basel). 2019 Jan 11;8(1):19. doi: 10.3390/antiox8010019.